Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Janssen
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 4 ans
A randomized, double-blind, placebo- and active-controlled, parallel-group study to evaluate the efficacy and safety of risperidone long-acting injectable for the prevention of mood episodes in the treatment of subjects with bipolar I disorder
To evaluate the efficacy of risperidone long-acting injectable (LAI) versus placebo in the prevention of a mood episode (recurrence event) in subjects with bipolar I disorder after a 12-week (3-month)...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
Study to Evaluate Imetelstat (JNJ-63935937) in Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Part 1: To evaluate the efficacy and safety of imetelstat in transfusion dependent subjects with low or intermediate-1 risk MDS that is relapsed/refractory to ESA treatment. Part 2: To compare the...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 4 ans
A Phase 2, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of VELCADE® in combination with Dexamethasone or VELCADE® in combination with Dexamethasone and Cyclophosphamide or VELCADE® in combination with Dexamethasone and Lenalidomide in Subjects with Multiple Myeloma who are Refractory to or Have Relapsed / progressed after Primary Therapy for Multiple Myeloma and have achieved stable disease after 4 cycles of VELCADE®/Dexamethasone therapy
The primary objective is to assess the efficacy of adding either Cyclophosphamide or Lenalidomide to the combination of Velcade® (bortezomib) and Dexamethasone in subjects with multiple myeloma who ar...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen Biologics B.V
Update Il y a 4 ans
A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 888 Administered Intravenously in Subjects with Idiopathic Pulmonary Fibrosis
• To determine the efficacy (as measured by pulmonary function) and safety of CNTO 888 in subjects with IPF.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag (Netherlands)
Update Il y a 4 ans
The effectiveness of a serious game for children with attention deficit hyperactivity disorder
Background and study aims An educational computer game (so called serious game) can possibly contribute to optimizing daily functioning of children with attention deficit hyperactivity disorder (ADHD)...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Thomas Janssens, PhD
Update Il y a 4 ans
The Effect of Odors on Asthma Symptoms
An extended replication of Jaen & Dalton (2014), the investigators aim to investigate the role of odors and associated trigger beliefs on symptom perception and airway inflammation in indi...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Janssen Pharmaceutical K.K
Update Il y a 4 ans
A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents with Irritability Associated with Autistic Disorder
The purpose of this study is to evaluate the efficacy of risperidone compared with placebo in children and adolescents with irritability associated with autistic disorder.
Country
None
organs
None
Specialty
None
More information
Woman and Man
Between 18 years
and 99 years
Janssen
Update Il y a 5 ans
Étude AQUILA : étude de phase 3 randomisée comparant l’efficacité du daratumumab avec celle d’un suivi actif chez des patients ayant un myélome multiple indolent.
Le myélome multiple est une maladie de la moelle osseuse caractérisée par la multiplication dans la moelle osseuse d’un plasmocyte anormal. Le rôle des plasmocytes est de produire les anticorps (immun...
Country
France
organs
Myélomes
Specialty
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
A Randomized, Open-Label, Multicenter Study to Assess the Safety and Tolerability of Doripenem Compared With Imipenem in the Treatment of Subjects With Complicated Intra-Abdominal Infections or Ventilator-Associated Pneumonia
The primary objective is to assess the safety and tolerability of doripenem 1 g infused over 4 hours at 8-hour intervals.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Harry Janssen, Prof. dr
Update Il y a 4 ans
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B
The purpose of this study is to investigate whether it is possible to augment the response of patients with HBeAg-positive chronic hepatitis B to entecavir by using a temporary peginterfer...
Country
China
,
Netherlands
,
Poland
,
Romania
,
Turkey
organs
None
Specialty
None
Closed trial
More information
Previous
7
8
9
10
11
12
13
14
15
16
Next